Eurofins Scientific SE (ERFSF)
OTCMKTS · Delayed Price · Currency is USD
79.26
-2.49 (-3.05%)
At close: Feb 11, 2026
Eurofins Scientific SE Revenue
In the year 2025, Eurofins Scientific SE had annual revenue of 7.30B EUR with 4.96% growth. Eurofins Scientific SE had revenue of 3.68B in the half year ending December 31, 2025, with 11.46% growth.
Revenue
7.30B EUR
Revenue Growth
+4.96%
P/S Ratio
1.58
Revenue / Employee
112.25K EUR
Employees
65,000
Market Cap
13.55B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.30B | 345.00M | 4.96% |
| Dec 31, 2024 | 6.95B | 436.40M | 6.70% |
| Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
| Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
| Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| Bioqual | 46.54M |
| Interpace Biosciences | 41.92M |
| Psychemedics | 19.69M |
| China New Energy Group Company | 12.51M |
| Aspira Women's Health | 9.34M |
| Longduoduo Company | 4.15M |
Eurofins Scientific SE News
- 1 day ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 1 day ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 2 days ago - Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026 • news - Onvista
- 7 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 8 days ago - Eurofins Scientific: Director/PDMR Shareholding - Business Wire
- 9 days ago - Eurofins Scientific: Weak Organic Growth Cyclical, Growth Will Normalize - Seeking Alpha
- 10 days ago - Eurofins Scientific SE (ERFSF) Full Year 2025 Earnings Call Highlights: Strong Performance ... - GuruFocus
- 10 days ago - Full Year 2025 Eurofins Scientific SE Earnings Call Transcript - GuruFocus